The Rising Influence of Rising Affluence

[DewDiligence]

BSX has big plans in China and other BRIC countries:

http://online.wsj.com/news/articles/SB10001424052702304244904579276161249753896

Boston Scientific Corp. is boosting staff, opening surgeon-training centers and eyeing acquisitions in China as it aims to offset sluggish medical-device sales back home in the U.S.

…The company is aiming for annual sales increases of 30% in China over the next five years, said Mr. Wang… Boston Scientific plans to expand its 400-member China-based sales and marketing staff by 24% in the next year and will create products specifically for the Chinese market, zeroing in on increasing rates of heart failure, strokes and gastrointestinal problems in the country.

…Boston Scientific has outlined an ambitious strategy to more than double sales in the so-called BRIC nations of Brazil, Russia, India and China from roughly 4% of sales at the end of 2012 to 10% by the end of 2017. Chief Financial Officer Jeffrey Capello, who is leaving the company at the end of this year, has said that the Chinese market for drug-eluting stents—small devices used to prop open clogged heart arteries—is about $500 million annually, and growing at about 15% to 20% a year.